This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

Hurry! $500 Savings Ends In:

  • 00
  • 00
  • 00
  • 00
December 4 - 8, 2022
Marriott Marquis San DiegoDelivered as a Hybrid Event

Adrian Bot, M.D., Ph.D.
Chief Scientific Officer and EVP, R&D at Capstan Therapeutics


Adrian Bot, M.D., Ph.D. is the founding Chief Scientific Officer and Executive Vice President of Research and Development at Capstan Therapeutics, a company developing next generation precision medicines. Previously, he held leadership roles at Kite Pharma and Kite, a Gilead Company, including Chief Scientific Officer and Vice President of Translational Medicine, respectively. Dr. Bot has 24 years of experience in biopharmaceutical industry with focus on discovery and development of targeted therapies in general, and immunotherapies in particular. He obtained his M.D. in Romania in 1993 and his Ph.D. in Biomedical Sciences at Mount Sinai School of Medicine in New York in 1998.

Agenda Sessions

  • Utilizing New Approaches to Develop Next-generation CAR Therapy